In the Research Letter titled “Global Production of Active Pharmaceutical Ingredients for US Generic Drugs Experiencing Shortages,” published online April 29, 2024, and in print on May 28, 2024, in Table 2, the number and percentage of facilities with and without active pharmaceutical ingredient shortages in Spain were changed to 15 (5.5%) and 12 (4.1%), respectively; in Germany, to 9 (3.3%) and 14 (4.8%), respectively; in Japan, to 7 (2.6%) and 14 (4.8%), respectively; and in France, to 8 (2.9%) and 13 (4.4%), respectively. This article has been corrected online.
